Trial Results Search
Clinical Trial Results: aleglitazar
-
Protocol Number: BC20265
Product Name: aleglitazar
Date of Report: To be Published
Phase: II
-
Protocol Number: BC20653
Product Name: aleglitazar
Date of Report: To be Published
Phase: II
-
Protocol Number: BP25328
Product Name: aleglitazar
Date of Report: To be Published
Phase: I
-
Protocol Number: BP25230
Product Name: aleglitazar
Date of Report: To be Published
Phase: I
A Pharmacokinetic Study of Aleglitazar in Healthy Chinese Volunteers
-
Protocol Number: BP25562
Product Name: aleglitazar
Date of Report: To be Published
Phase: I
A Pharmacokinetics Study of Aleglitazar in Combination With Digoxin in Healthy Volunteers
-
Protocol Number: BP25329
Product Name: aleglitazar
Date of Report: To be Published
Phase: I
A Study of Aleglitazar in Combination With Aspirin in Healthy Volunteers
-
Protocol Number: BP25330
Product Name: aleglitazar
Date of Report: To be Published
Phase: I
A Study of Aleglitazar in Combination With Ibuprofen in Healthy Volunteers
-
Protocol Number: BC28035
Product Name: aleglitazar
Date of Report: To be Published
Phase: III
-
Protocol Number: YC28036
Product Name: aleglitazar
Date of Report: To be Published
Phase: III
-
Protocol Number: WC28325
Product Name: aleglitazar
Date of Report: To be Published
Phase: III
-
Protocol Number: BP25559
Product Name: aleglitazar
Date of Report: To be Published
Phase: I
A Study of Aleglitazar in Combination With Oral Contraceptive Healthy Volunteers
-
Protocol Number: YC28037
Product Name: aleglitazar
Date of Report: To be Published
Phase: III
-
Protocol Number: BM17864
Product Name: aleglitazar
Date of Report: To be Published
Phase: II
-
Protocol Number: BC28034
Product Name: aleglitazar
Date of Report: To be Published
Phase: III
-
Protocol Number: BC22419
Product Name: ALEGLITAZAR
Date of Report: To be Published
Phase: II
A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment
-
Protocol Number: WC28038
Product Name: aleglitazar
Date of Report: To be Published
Phase: II
-
Protocol Number: BC28027
Product Name: aleglitazar
Date of Report: To be Published
Phase: III
-
Protocol Number: BC25445
Product Name: aleglitazar
Date of Report: To be Published
Phase: II
-
Protocol Number: BP25561
Product Name: aleglitazar
Date of Report: To be Published
Phase: I
-
Protocol Number: BC22140
Product Name: ALEGLITAZAR
Date of Report: To be Published
Phase: III
-
Protocol Number: BP25240
Product Name: aleglitazar [aleglitazar]
Date of Report: 01.02.2013
Phase: I
About This Database
This database is populated with information on the results of Roche-sponsored clinical trials.